PEAK1 and ovarian cancer: Since PEAK1 was activated by CDC5L and miR‐542‐3p regulated the malignant biological behaviors of ovarian cancer cells through targeting the CDC5L 3′UTR, we next examined whether PEAK1 and downstream pathways were involved in the tumor‐suppression effect of miR‐542‐3p on ovarian cancer cells.